Reviewed by Michael Gill, B. Sc.
11 Chronic Spontaneous Urticaria Clinical Trials Near Me
Top Hospitals for Chronic Spontaneous Urticaria Clinical Trials
Image of Treasure Valley Medical Research in Idaho.
Treasure Valley Medical Research
Boise
2Active Trials
4All Time Trials for Chronic Spontaneous Urticaria
2019First Chronic Spontaneous Urticaria Trial
Image of Dawes Fretzin Clinical Research in Indiana.
Dawes Fretzin Clinical Research
Indianapolis
2Active Trials
2All Time Trials for Chronic Spontaneous Urticaria
2020First Chronic Spontaneous Urticaria Trial
Top Cities for Chronic Spontaneous Urticaria Clinical Trials
Image of Toronto in Ontario.
Toronto
6Active Trials
Investigational Site Number :1240005Top Active Site
Image of Tulsa in Oklahoma.
Tulsa
5Active Trials
Vital Prospects Clinical Research Institute, P.C.-Site Number:8400002Top Active Site
Chronic Spontaneous Urticaria Clinical Trials by Phase of Trial
Phase < 1 Chronic Spontaneous Urticaria Clinical Trials
1Active Chronic Spontaneous Urticaria Clinical Trials
1Number of Unique Treatments
2Number of Active Locations
Chronic Spontaneous Urticaria Clinical Trials by Age Group
< 18 Chronic Spontaneous Urticaria Clinical Trials
1Active Chronic Spontaneous Urticaria Clinical Trials
Most Recent Chronic Spontaneous Urticaria Clinical Trials
Top Treatments for Chronic Spontaneous Urticaria Clinical Trials
Treatment Name
Active Chronic Spontaneous Urticaria Clinical Trials
All Time Trials for Chronic Spontaneous Urticaria
First Recorded Chronic Spontaneous Urticaria Trial
LOU064 (open-label)
2
2
2021
Lirentelimab (AK002)
1
1
2022
Dupilumab
1
2
2018
barzolvolimab
1
2
2022
rilzabrutinib
1
1
2021
Recently Completed Studies with FDA Approved Treatments for Chronic Spontaneous Urticaria
Treatment
Year
Sponsor
LOU064
2019
Novartis Pharmaceuticals
Ligelizumab
2018
Novartis Pharmaceuticals
Ligelizumab
2018
Novartis Pharmaceuticals

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 10th, 2021

Last Reviewed: October 21st, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.